Andes-1560

N/A

Report date: 2026/01/19 14:41:31

Base Information

Drug NameAndes-1560

Drug Alias Namelentivirus vector-delivered anti-ncmtRNA shRNA (Andes Biotechnologies)lentivirus vector-delivered shRNA inhibitors of non-coding mitochondrial RNA (Andes Biotechnologies)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAndes Biotechnologies

China Registration ClassN/A

Develop Information

Active CompaniesAndes Biotechnologies

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A